India to Kyrgyzstan: Velpatasvir Export Trade Route

The India to Kyrgyzstan Velpatasvir corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $128.8K USD. The route is dominated by ROGER MEDICALS, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's velpatasvir manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $128.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with velpatasvir's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 14.7%, placing it at rank #10 among India's top velpatasvir export destinations globally.

On the import side, key buyers of Indian velpatasvir in Kyrgyzstan include STATE-OWNED ENTERPRISE. STATE-OWNED ENTERPRISE is the single largest importer with 1 shipments valued at $128.8K USD.

India's velpatasvir exports to Kyrgyzstan are driven primarily by a handful of large-scale manufacturers. ROGER MEDICALS with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Kyrgyzstan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ROGER MEDICALS — together account for 100% of total trade value on this route. The average shipment value of $128.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, STATE-OWNED ENTERPRISE is the largest importer with 1 shipments worth $128.8K USD — representing 100% of all velpatasvir imports from India on this route.